Table 2.
Characteristics of mRNA and miRNA expression profiling of the nasopharyngeal carcinoma.
| GEO ID | Platform | Samples (N:P) | Time | Author |
|---|---|---|---|---|
| mRNA expression profiling | ||||
| GSE53819 | GPL6480Agilent-014850 Whole Human Genome Microarray 4x44K G4112F (Probe Name version) | 18:18 | 2014 | Qian CN |
| GSE13597 | GPL96[HG-U133A] Affymetrix Human Genome U133A Array | 3:25 | 2009 | Wei W |
| GSE12452 | GPL570[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array | 10:31 | 2008 | Ahlquist P |
| miRNA expression profiling | ||||
| GSE32906 | GPL11350 Illumina Custom Prostate Cancer DASL Panel miRNA | 6:16 | 2014 | Luo Z |
| GSE46172 | GPL16770Agilent-031181 Unrestricted_Human_miRNA_V16.0_Microarray (miRBase release 16.0 miRNA ID version) | 4:4 | 2013 | Bethony JM |
| GSE22587 | GPL8933Illumina Human Beta-version microRNA expression BeadChip | 4:8 | 2012 | YANG S |
| GSE32960 | GPL14722microRNA array | 18:312 | 2012 | Ma J |
| GSE36682 | Human miRNA 1K | 6:62 | 2012 | Wei R |
N – normal samples; P – patients’ samples.